Treating patients not numbers: The benefit and burden of lowering TSH newborn screening cut-offs

Archives of Disease in Childhood

Volumn 96, Issue 2, 2011, Pages 121-122

  Krude, Heiko ^a   Blankenstein, Oliver ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

CONGENITAL HYPOTHYROIDISM; DISEASE COURSE; EDITORIAL; HUMAN; NEWBORN SCREENING; NORMAL VALUE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CONGENITAL HYPOTHYROIDISM; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; REFERENCE VALUES; THYROTROPIN; THYROXINE;

EID: 78651433422     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.174466     Document Type: Editorial

References (10)

1. Osler W. Trans Congress of American Physicians and Surgeons, 1897;4:169-206.
2. Klein AH, Agustin AV, Foley TP Jr. Successful laboratory screening for congenital hypothyroidism. Lancet 1974;2:77-9.
3. Oerbeck B, Sundet K, Kase BF, et al. Congenital hypothyroidism: infl uence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003;112:923-30.
4. Rovet JF. Children with congenital hypothyroidism and their siblings: do they really differ? Pediatrics 2005;115:e52-7.
5. Korada SM, Pearce M, Ward Platt MP, et al. Diffi culties in selecting an appropriate neonatal thyroid stimulating hormone (TSH) screening threshold. Arch Dis Child 2010;95:169-73.
6. Alm J, Hagenfeldt L, Larsson A, et al. Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed) 1984;289:1171-5.
7. Oken E, Braverman LE, Platek D, et al. Neonatal thyroxine, maternal thyroid function, and child cognition. J Clin Endocrinol Metab 2009;94:497-503.
8. Elmlinger MW, Kühnel W, Lambrecht HG, et al. Reference intervals from birth to adulthood for serum thyroxine (T4), triiodothyronine (T3), free T3, free T4, thyroxine binding globulin (TBG) and thyrotropin (TSH). Clin Chem Lab Med 2001;39:973-9.
9. Hewlett J, Waisbren SE. A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening. J Inherit Metab Dis 2006;29:677-82.
10. Watson MS. Current status of newborn screening: decision-making about the conditions to include in screening programs. Ment Retard Dev Disabil Res Rev 2006;12:230-5.